SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 56 filers reported holding SAVARA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104 | -8.8% | 27,320 | -23.2% | 0.00% | – |
| Q2 2023 | $114 | +100.0% | 35,559 | +22.8% | 0.00% | – |
| Q1 2023 | $57 | +26.7% | 28,960 | 0.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 28,960 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +28.6% | 28,960 | +27.2% | 0.00% | – |
| Q2 2022 | $35,000 | +20.7% | 22,760 | +4.1% | 0.00% | – |
| Q1 2022 | $29,000 | +38.1% | 21,860 | +26.7% | 0.00% | – |
| Q4 2021 | $21,000 | -12.5% | 17,260 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -17.2% | 17,260 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -27.5% | 17,260 | -9.2% | 0.00% | – |
| Q1 2021 | $40,000 | +185.7% | 19,003 | +61.0% | 0.00% | – |
| Q4 2020 | $14,000 | – | 11,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |